Table 2. Characteristics of participants stratified by vital status.
Variables | Survivors | Decedents | P value | ||||
|
|
||||||
No. | % | Mean (SD) | No. | % | Mean (SD) | ||
Total No. | 1291 | 88 | 169 | 12 | |||
HGF, ng/ml | 0.23 (0.09) | 0.26 (0.11) | 0.009 | ||||
Age, years | 61 (10) | 72 (9) | <0.0001 | ||||
Male sex | 487 | 38 | 103 | 61 | <0.0001 | ||
Body mass indexa | 23 (3) | 22 (3) | 0.016 | ||||
Systolic BP, mm Hg | 132 (20) | 144 (24) | <0.0001 | ||||
Diastolic BP, mm Hg | 79 (11) | 81 (12) | 0.056 | ||||
HbA1c, % | 5.2 (0.7) | 5.4 (1.2) | 0.033 | ||||
Blood urea nitrogen, mmol/l | 5.7 (1.4) | 6.4 (1.9) | <0.0001 | ||||
Creatinine, µmol/l | 74 (15) | 85 (22) | <0.0001 | ||||
Uric acid, µmol/l | 286 (83) | 321 (89) | <0.0001 | ||||
C-reactive proteinb, mg/dl | 0.19 | 0.22 | 0.0004 | ||||
Range | 0.1–11.5 | 0.1–5.2 | |||||
Albumin, g/l | 44 (2) | 42 (3) | <0.0001 | ||||
Total cholesterol, mmol/l | 5.2 (0.9) | 4.9 (0.9) | <0.0001 | ||||
HDL cholesterol, mmol/l | 1.5 (0.4) | 1.5 (0.4) | 0.485 | ||||
Triglyceridesb, mmol/l | 1.10 | 1.09 | 0.837 | ||||
Range | 0.32–14.4 | 0.34–4.73 | |||||
AST, units/l | 28 (5) | 28 (6) | 0.485 | ||||
ALT, units/l | 26 (4) | 26 (3) | 0.460 | ||||
γ-GTPb, units/l | 18 | 22 | 0.043 | ||||
Range | 1–310 | 3–896 | |||||
Smoking | 187 | 15 | 47 | 28 | <0.0001 | ||
Alcohol | 268 | 21 | 40 | 24 | 0.429 | ||
Antihypertensive medication | 234 | 18 | 48 | 28 | 0.02 | ||
Antihyperlipidemic medication | 60 | 5 | 12 | 7 | 0.228 | ||
Antidiabetic medication | 32 | 2 | 8 | 5 | 0.148 |
Data are mean (SD), geometric mean, range, or percent.
Abbreviations: HGF, hepatocyte growth factor; SD, standard deviation; BP, blood pressure; HbA1c, glycosylated hemoglobin A1c; HDL, high density lipoprotein; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase.
aWeight (kg)/height (m)2.
bThese variables are shown in the original scale after analysis using log (natural)-transformed values.